IE
ITRM

Israel Englander’s Iterum Therapeutics ITRM Stock Holding History

Israel Englander’s Portfolio ITRM Stock Details ITRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-28,043
Closed -$43.2K – 6218
2024
Q1 		$43.2K Buy
+28,043
New +$45.6K ﹤0.01% 5705
2022
Q3 		– Sell
-5,873
Closed -$18K – 7274
2022
Q2 		$18K Buy
+5,873
New +$22K ﹤0.01% 6513
2021
Q4 		– Sell
-8,713
Closed -$73K – 7100
2021
Q3 		$73K Sell
8,713
-161,979
-95% -$2M ﹤0.01% 6515
2021
Q2 		$5.91M Buy
170,692
+165,678
+3,304% +$3.59M ﹤0.01% 2533
2021
Q1 		$106K Buy
+5,014
New +$119K ﹤0.01% 5678
2019
Q4 		– Sell
-1,715
Closed -$151K – 4420
2019
Q3 		$151K Sell
1,715
-228
-12% -$22.2K ﹤0.01% 3868
2019
Q2 		$201K Sell
1,943
-195
-9% -$21.7K ﹤0.01% 3758
2019
Q1 		$258K Sell
2,138
-160
-7% -$14.7K ﹤0.01% 3632
2018
Q4 		$173K Sell
2,298
-1,069
-32% -$101K ﹤0.01% 3435
2018
Q3 		$338K Sell
3,367
-8,064
-71% -$1.05M ﹤0.01% 3429
2018
Q2 		$1.87M Buy
+11,431
New +$2.06M ﹤0.01% 2448

Other funds holding ITRM

AF
Apollon Financial Mount Pleasant, South Carolina $848M AUM 27.31% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
KFS
Kelly Financial Services Braintree, Massachusetts $467M AUM 21.13% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BBPWM
Blue Bell Private Wealth Management Blue Bell, Pennsylvania $802M AUM 22.13% 1-Year Est. Return

Israel Englander's ITRM Position: Q2 2024 in Review

Israel Englander sold out of Iterum Therapeutics (ITRM) in Q2 2024, closing a stake of 28,043 shares — an estimated $43.2K sold.

Israel Englander first reported a position in ITRM in Q2 2018 and held it in 11 quarters. The position peaked at $5.91M in Q2 2021. 15 funds tracked by Wall St. Rank hold ITRM as of Q2 2024.

  • Israel Englander reported no remaining Iterum Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Israel Englander sold 28,043 Iterum Therapeutics shares in Q2 2024, an estimated $43.2K.
  • Israel Englander first reported a position in Iterum Therapeutics in Q2 2018 and held it in 11 quarters.
  • Israel Englander's Iterum Therapeutics position peaked at $5.91M in Q2 2021.
  • 15 funds tracked by Wall St. Rank held Iterum Therapeutics as of Q2 2024.

Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.